Yen-Ping Kuo Mark, Huang Jehn-Shyun, Kok Sang-Heng, Kuo Ying-Shiung, Chiang Chun-Pin
School of Dentistry, National Taiwan University Hospital, Taipei, Taiwan.
J Oral Pathol Med. 2002 Jan;31(1):16-22. doi: 10.1046/j.0904-2512.2001.10055.x.
Alterations in p21WAF1 protein expression have been observed in a wide variety of human cancers by immunohistochemistry, and both decreased and increased levels of p21WAF1 protein expression have been shown to correlate with poor prognosis.
To examine the relation between p21WAF1 protein expression and prognosis in oral squamous cell carcinomas (SCCs), we performed an immunohistochemical study with antip21WAF1 antibody on 43 oral SCCs. Immunostaining results were then correlated with p53 protein levels, clinicopathological parameters of the tumors and overall patient survival.
Of the 43 patients, 31 (72%) had tumors with positive p21WAF1 nuclear staining and 27 (63%) had tumors with p53 nuclear staining. There was no significant correlation between p21WAF1 and p53 protein expressions and both mutant p53-containing oral SCCs overexpressed p21WAF1 protein. In addition, no significant correlation was found between the p21WAF1 expression and the patients' age, sex, oral habit, cancer location, or primary tumor TNM status at the time of initial presentation. The Kaplan-Meier analysis showed a significant correlation between p21WAF1 protein overexpression and poor patient overall survival (P = 0.049). When p53 and p21WAF1 were evaluated together, the 5-year overall survival was lowest in p53(+)-p21WAF1(+) patients and highest in p53(-)-p21WAF1(-) patients (P = 0.057).
Combined evaluation of p21WAF1 and p53 expressions may be useful in estimating the prognosis of patients with oral SCCs in Taiwan.
通过免疫组织化学在多种人类癌症中观察到p21WAF1蛋白表达的改变,并且p21WAF1蛋白表达水平的降低和升高均已显示与预后不良相关。
为了研究p21WAF1蛋白表达与口腔鳞状细胞癌(SCC)预后之间的关系,我们用抗p21WAF1抗体对43例口腔SCC进行了免疫组织化学研究。然后将免疫染色结果与p53蛋白水平、肿瘤的临床病理参数以及患者的总生存率相关联。
43例患者中,31例(72%)肿瘤p21WAF1核染色阳性,27例(63%)肿瘤p53核染色阳性。p21WAF1和p53蛋白表达之间无显著相关性,并且含突变p53的口腔SCC均过度表达p21WAF1蛋白。此外,在初次就诊时,未发现p21WAFI表达与患者年龄、性别、口腔习惯、癌症位置或原发肿瘤TNM状态之间存在显著相关性。Kaplan-Meier分析显示p21WAF1蛋白过表达与患者总生存率差显著相关(P = 0.049)。当同时评估p53和p21WAF1时,5年总生存率在p53(+) - p21WAF1(+)患者中最低,在p53(-) - p21WAF1(-)患者中最高(P = 0.057)。
联合评估p21WAF1和p53表达可能有助于评估台湾口腔SCC患者的预后。